DYADIC INTERNATIONAL
1.9100
25-11月-24 16:45:01
15 分の遅延
株式
-0.0200
-1.04%
本日の幅
1.7900 - 2.0000
ISIN
N/A
ソース
NASDAQ
-
Dyadic to Report 2021 Year-End Financial Results on Tuesday, March 29, 2022
15 3 2022 16:30:00 提供 Nasdaq GlobeNewswire
-
10 2 2022 08:30:00 提供 Nasdaq GlobeNewswire
-
Dyadic International’s CEO Mark Emalfarb to Present at BIO CEO & Investor Conference
07 2 2022 08:30:01 提供 Nasdaq GlobeNewswire
-
20 1 2022 08:30:00 提供 Nasdaq GlobeNewswire
-
Dyadic Announces a NIIMBL Coronavirus Grant Under the White House’s American Rescue Plan
22 12 2021 09:12:47 提供 Nasdaq GlobeNewswire
-
17 12 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
Dyadic Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress
10 11 2021 16:00:00 提供 Nasdaq GlobeNewswire
-
Dyadic Appoints Chief Business Officer to Executive Leadership Team
09 11 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
Dyadic to Report Third Quarter 2021 Financial Results on Wednesday, November 10, 2021
27 10 2021 16:30:00 提供 Nasdaq GlobeNewswire
-
Dyadic to Present at H.C. Wainwright 23rd Annual Global Investment Conference
10 9 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
28 6 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
Dyadic announces development of COVID-19 Vaccine in India
26 5 2021 08:30:01 提供 Nasdaq GlobeNewswire
-
Dyadic to Present at Upcoming Events
03 5 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
22 4 2021 08:30:01 提供 Nasdaq GlobeNewswire
-
29 3 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
Dyadic and Medytox To Develop Vaccines Against COVID-19 Variants
23 3 2021 09:00:01 提供 Nasdaq GlobeNewswire
-
Dyadic and Medytox To Develop Vaccines Against COVID-19 Variants
22 3 2021 21:00:00 提供 Nasdaq GlobeNewswire
-
Dyadic and Medytox To Develop Vaccines Against COVID-19 Variants
22 3 2021 08:30:00 提供 Nasdaq GlobeNewswire